Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMEED for Hyposecretory Dry Eye
NCT05598242Phase 3Completed
- Sponsor
- Hospital Nacional Profesor Alejandro Posadas
- Start
- Feb 2019
- Primary completion
- Sep 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Amniotic membrane extract eye drops in dry eye syndrome (DED) (2 arms), sponsored by Hospital Nacional Profesor Alejandro Posadas. Primary endpoint: Lissamine green conjunctival staining score at 1 month. Started Feb 2019; status: completed.
02
Drugs
Amniotic membrane extract eye drops
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT05598242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05598242.